Intestinal metabolites, chronic kidney disease and renal transplantation
Should we aim for oral health to improve outcomes in chronic kidney disease?
Skeletal fractures in patients on renal replacement therapy
Cum grano salis
Intermittent smoking and chronic kidney disease
Opponent's comments
Opponent's comments
Moderator's view
Targeting the podocyte cytoskeleton
Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease
Novel iron-containing phosphate binders and anemia treatment in CKD
Progress in the treatment of atherosclerotic renovascular disease
Neurological complications in chronic kidney disease patients
Curcumin ameliorates nephrosclerosis via suppression of histone acetylation independent of hypertension
Acetazolamide enhances the release of urinary exosomal aquaporin-1
Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury
Clinical adjudication in acute kidney injury studies
Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis
Risk of fracture in adults on renal replacement therapy
Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly
Smoking patterns and chronic kidney disease in US Hispanics
Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4
Prevalence and distribution of (micro)albuminuria in toddlers
Prenatal diagnosis of fetal multicystic dysplastic kidney via high-resolution whole-genome array
Body mass index trend in haemodialysis patients
High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity
The effects of resistance exercise and oral nutritional supplementation during hemodialysis on indicators of nutritional status and quality of life
The influence of renal transplantation on retained microbial–human co-metabolites
Efficacy and safety of antibody induction therapy in the current era of kidney transplantation
Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies
The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients